Cargando…

A Novel Structural Framework for α(1A/D)-Adrenoceptor Selective Antagonists Identified Using Subtype Selective Pharmacophores

In this study four and five-feature pharmacophores for selective antagonists at each of the three α(1)-adrenoceptor (AR) subtypes were used to identify novel α(1)-AR subtype selective compounds in the National Cancer Institute and Tripos LeadQuest databases. 12 compounds were selected, based on dive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stoddart, Emily S., Senadheera, Sevvandi, MacDougall, Iain J. A., Griffith, Renate, Finch, Angela M.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091868/ https://www.ncbi.nlm.nih.gov/pubmed/21572949 http://dx.doi.org/10.1371/journal.pone.0019695

Ejemplares similares

A Selective Pharmacophore Model for β(2)-Adrenoceptor Agonists
por: Xing, Rui-Juan, et al.
Publicado: (2009)

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2020)

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
por: Proudman, Richard G.W., et al.
Publicado: (2022)

The selectivity of α‐adrenoceptor agonists for the human α1A, α1B, and α1D‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2021)

Chemically Homogenous Compounds with Antagonistic Properties at All α(1)-Adrenoceptor Subtypes but not β(1)-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats
por: Pytka, Karolina, et al.
Publicado: (2016)

The signaling and selectivity of α‐adrenoceptor agonists for the human α2A, α2B and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2022)

Novel selective β(1)-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease
por: Baker, Jillian G., et al.
Publicado: (2017)

β(1) Adrenoceptor antagonistic effects of the supposedly selective β(2) adrenoceptor antagonist ICI 118,551 on the positive inotropic effect of adrenaline in murine hearts
por: Pecha, Simon, et al.
Publicado: (2015)

Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer
por: Mihalopoulos, Meredith, et al.
Publicado: (2020)

The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers
por: Batty, Mallory, et al.
Publicado: (2016)

Combining spatial and chemical information for clustering pharmacophores
por: Zhou, Lingxiao, et al.
Publicado: (2014)

Search for new α1a-adrenoceptor-selective antagonist for treating lower urinary tract symptoms associated with benign prostatic hyperplasia
por: Khurana, Naval, et al.
Publicado: (2007)

"Ejaculatory disorders and α(1)-adrenoceptor antagonists therapy: clinical and experimental researches"
por: Grasso, Marco, et al.
Publicado: (2006)

Effects of α-Adrenoceptor Antagonists on ABCG2/BCRP-Mediated Resistance and Transport
por: Takara, Kohji, et al.
Publicado: (2012)

Use of α1‐adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease
por: Latvala, Laura, et al.
Publicado: (2022)

Expression of Adrenoceptor Subtypes in Preterm Piglet Heart Is Different to Term Heart
por: Kim, Min Young, et al.
Publicado: (2014)

Celiprolol: A Unique Selective Adrenoceptor Modulator
por: Nawarskas, James J., et al.
Publicado: (2017)

Are Selective Beta-Adrenoceptor Blocking Drugs an Advantage?
por: Kendall, M.J.
Publicado: (1981)

The Characteristics and Distribution of α2D-, α2B- and α2C-Adrenoceptor Subtypes in Goats
por: Xu, Ming, et al.
Publicado: (2022)

Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist
por: Kotańska, Magdalena, et al.
Publicado: (2017)

“Balancing” balancing selection? Assortative mating at the major histocompatibility complex despite molecular signatures of balancing selection
por: Slade, Joel W. G., et al.
Publicado: (2019)

The cytotoxicity of the α1-adrenoceptor antagonist prazosin is linked to an endocytotic mechanism equivalent to transport-P
por: Fuchs, Robert, et al.
Publicado: (2015)

Does prostate volume affect the efficacy of α1D/A: Adrenoceptor antagonist naftopidil?
por: Tanuma, Yasushi, et al.
Publicado: (2016)

Discovery of CNS-Like D3R-Selective Antagonists Using 3D Pharmacophore Guided Virtual Screening
por: Lee, June Hyeong, et al.
Publicado: (2018)

1133. Qualitative Analysis of Pharmacists’ Therapeutic Reasoning Processes Applied to Antimicrobial Selection and Stewardship Activities
por: Gruenberg, Katherine, et al.
Publicado: (2020)

Caveolin Contributes to the Modulation of Basal and β-Adrenoceptor Stimulated Function of the Adult Rat Ventricular Myocyte by Simvastatin: A Novel Pleiotropic Effect
por: Pugh, Sara D., et al.
Publicado: (2014)

The muscarinic receptor antagonist propiverine exhibits α(1)-adrenoceptor antagonism in human prostate and porcine trigonum
por: Wuest, Melinda, et al.
Publicado: (2011)

Cutoff level of prostate volume to predict the efficacy of α1-D/A adrenoceptor antagonist, naftopidil
por: Tanuma, Yasushi, et al.
Publicado: (2021)

A Systematic Review of Inverse Agonism at Adrenoceptor Subtypes
por: Michel, Martin C., et al.
Publicado: (2020)

Expression and Signaling of β-Adrenoceptor Subtypes in the Diabetic Heart
por: Erdogan, Betul R., et al.
Publicado: (2020)

Exploring the kinetic selectivity of drugs targeting the β(1)‐adrenoceptor
por: Sykes, David A., et al.
Publicado: (2022)

The role of α(1)- and α(2)-adrenoceptor subtypes in the vasopressor responses induced by dihydroergotamine in ritanserin-pretreated pithed rats
por: Rivera-Mancilla, Eduardo, et al.
Publicado: (2017)

Crystal structures, absolute configurations and molecular docking studies of naftopidil enantiomers as α(1D)-adrenoceptor antagonists
por: Xu, Wei, et al.
Publicado: (2017)

Conformationally Selective RNA Aptamers Allosterically Modulate the β(2)-Adrenoceptor
por: Kahsai, Alem W., et al.
Publicado: (2016)

Pharmacophore Selection and Redesign of Non-nucleotide Inhibitors of Anthrax Edema Factor
por: Schein, Catherine H., et al.
Publicado: (2012)

Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor
por: Suno, Ryoji, et al.
Publicado: (2018)

Therapeutic Potential of Selectively Targeting the α(2C)-Adrenoceptor in Cognition, Depression, and Schizophrenia—New Developments and Future Perspective
por: Uys, Madeleine Monique, et al.
Publicado: (2017)

Size‐based protocol optimization using automatic tube current modulation and automatic kV selection in computed tomography
por: MacDougall, Robert D., et al.
Publicado: (2016)

Development of Androgen-Antagonistic Coumarinamides with a Unique Aromatic Folded Pharmacophore
por: Koga, Hitomi, et al.
Publicado: (2020)

Role of α2-Adrenoceptor Subtypes in Suppression of L-Type Ca(2+) Current in Mouse Cardiac Myocytes
por: Evdokimovskii, Edward V., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5bkllgq6h0n7365764l7md4sv8